About Atrey Pharmaceuticals
Atrey Pharmaceuticals is a Healthcare company. Manufacturing of Ayurvedic and herbal products in India. Its Indian entity Atrey Pharmaceuticals Private Limited reported revenue of ₹7.76 Cr. Atrey Pharmaceuticals offers products and services including Ayurvedic Extracts and Tablets and Capsules. Its focus areas include Pharmaceuticals, Herbal Products, Ayurvedic Remedies and Natural Products.
Company details
Atrey Pharmaceuticals was established in 2006 as a subsidiary of Shantilal Ambalal and is engaged in the manufacturing and marketing of Ayurvedic and herbal products for domestic and global markets. Over 400 products across categories like extracts, tablets, and oils are offered, with operations supported by in-house RD and certifications such as GMP and ISO 9001:2008. The facility in Ahmedabad complies with international standards, enabling customized formulations and quick product development for regulatory needs. Products are well-received and marketed under brands like Vedaone.
- SectorsHealthcare
- Email••••••••
- Website atreypharma.com
- Social LinkedIn
- Legal Name Atrey Pharmaceuticals Private Limited
- Date of Incorporation 26 Apr, 2013
- Jurisdiction Ahmedabad, Gujarat, India
- Indian entity revenue₹7.76 Cr
FY 2025 · +36% YoY
- Indian entity net profit₹1.7 Lakh
FY 2025 · 0% margin
- Indian entity EBITDA₹41.6 Lakh
FY 2025 · 5% margin
Associated legal entities of Atrey Pharmaceuticals
Atrey Pharmaceuticals operates through Atrey Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Atrey Pharmaceuticals Private Limited CIN U24100GJ2013PTC074736 | Active | 26 Apr 2013 | Ahmedabad, Gujarat | ₹7.8 Cr | 2 | View details |
Products & Services of Atrey Pharmaceuticals
Atrey Pharmaceuticals offers a comprehensive portfolio of products and services, including Ayurvedic Extracts and Tablets and Capsules.
Extracts such as powder and paste are produced for health applications
Tablets and capsules are manufactured for various therapeutic uses
Board of directors of Atrey Pharmaceuticals Private Limited (Atrey Pharmaceuticals)
Atrey Pharmaceuticals Private Limited is the primary company behind Atrey Pharmaceuticals. The board of Atrey Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Minish Shantilal Shah, appointed in 2013. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Minish Shantilal Shah DIN 06556088 | Director | 26 Apr 2013 | 13 yrs 6 mo | Atrey Pharmaceuticals Private Limited |
| Naman Minish Shah DIN 06556265 | Director | 26 Apr 2013 | 13 yrs 6 mo | Atrey Pharmaceuticals Private Limited |
Financials of Atrey Pharmaceuticals
Figures of Atrey Pharmaceuticals Private Limited, the primary company behind Atrey Pharmaceuticals, for FY 2025. Revenue was ₹7.76 Cr (+36% year on year). Net profit was ₹1.7 Lakh (0% margin). EBITDA was ₹41.6 Lakh (5% margin). Revenue has grown at a compounded annual rate of +18% over three years and +11% over five years.
- ₹7.76 CrRevenue · FY 2025 · +36% YoY
- ₹1.7 LakhNet profit · 0% margin
- ₹41.6 LakhEBITDA · 5% margin
- ₹29 LakhPaid-up capital
- +18%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Atrey Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Atrey Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Atrey Pharmaceuticals
The primary company behind Atrey Pharmaceuticals, Atrey Pharmaceuticals Private Limited, reported revenue of ₹7.76 Cr for FY 2025, up 36% year on year.
Atrey Pharmaceuticals was established in 2006 as a subsidiary of Shantilal Ambalal and is engaged in the manufacturing and marketing of Ayurvedic and herbal products for domestic and global markets. Over 400 products across categories like extracts, tablets, and oils are offered, with operations supported by in-house RD and certifications such as GMP and ISO 9001:2008. The facility in Ahmedabad complies with international standards, enabling customized formulations and quick product development for regulatory needs. Products are well-received and marketed under brands like Vedaone.
Atrey Pharmaceuticals offers Ayurvedic Extracts and Tablets and Capsules.
Atrey Pharmaceuticals operates through Atrey Pharmaceuticals Private Limited.
The legal entities of Atrey Pharmaceuticals currently have 2 directors, including Minish Shantilal Shah, Naman Minish Shah.